Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy
View ORCID ProfileSohyun Hwang, Jaejoon Lim, Haeyoun Kang, Ju-Yeon Jeong, Je-Gun Joung, Jinhyung Heo, Daun Jung, Kyunggi Cho, Hee Jung An
doi: https://doi.org/10.1101/2022.09.21.22280225
Sohyun Hwang
1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
2CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Korea
Jaejoon Lim
3Department of Neurosurgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Haeyoun Kang
1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Ju-Yeon Jeong
2CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Korea
Je-Gun Joung
2CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Korea
4Department of Biomedical Science, CHA University, Seongnam, Korea
Jinhyung Heo
1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Daun Jung
1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Kyunggi Cho
3Department of Neurosurgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
Hee Jung An
1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
2CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Korea

Data Availability
All expression data are available in the GEO Database (https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE207753.
Posted September 23, 2022.
Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy
Sohyun Hwang, Jaejoon Lim, Haeyoun Kang, Ju-Yeon Jeong, Je-Gun Joung, Jinhyung Heo, Daun Jung, Kyunggi Cho, Hee Jung An
medRxiv 2022.09.21.22280225; doi: https://doi.org/10.1101/2022.09.21.22280225
Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy
Sohyun Hwang, Jaejoon Lim, Haeyoun Kang, Ju-Yeon Jeong, Je-Gun Joung, Jinhyung Heo, Daun Jung, Kyunggi Cho, Hee Jung An
medRxiv 2022.09.21.22280225; doi: https://doi.org/10.1101/2022.09.21.22280225
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)